Search results for "Vaccination"


 
Results 1 - 10 of about 504 for "Vaccination".
Sort by: Relevance | Newest | Oldest

ACP urges adults to get their influenza vaccine during National Influenza Vaccination Week

ACP is urging all adults to get vaccinated as influenza season, holiday gatherings, and winter weather are here, along with the continued presence of COVID-19 and respiratory syncytial virus.
https://acpinternist.org/weekly/archives/2023/12/05/5.htm
5 Dec 2023

RSV vaccines new tool for physicians

The CDC's Advisory Committee on Immunization Practices recommended in June that adults ages 60 years and older may receive a single dose of an RSV vaccine, using shared clinical decision making.
https://immattersacp.org/archives/2023/10/rsv-vaccines-new-tool-for-physicians.htm
1 Oct 2023

CDC publishes recommendations on use of RSV vaccines

The two vaccines for respiratory syncytial virus (RSV) were approved by the FDA for older adults in May.
https://immattersacp.org/weekly/archives/2023/08/01/4.htm
1 Aug 2023

Recombinant flu vaccine appears to provide benefit in patients ages 50 to 64 years

An industry-funded study compared a high-dose recombinant influenza vaccine with one of two standard-dose egg-based vaccines over two flu seasons and found patients who received a high-dose vaccine were less likely to test positive for flu.
https://acpinternist.org/weekly/archives/2023/12/19/2.htm
19 Dec 2023

ACIP updates flu vaccination recommendations

The Advisory Committee on Immunization Practices (ACIP) issued its annual update on flu vaccines, including a change in recommendations regarding vaccination of people with egg allergies.
https://immattersacp.org/weekly/archives/2023/08/29/1.htm
29 Aug 2023

New vaccines are on the scene

This month's issue addresses new vaccines, screening for anxiety, and detecting and treating loneliness.
https://immattersacp.org/archives/2023/10/new-vaccines-are-on-the-scene.htm
1 Oct 2023

Modeling study finds RSV vaccines cost-effective for older U.S. adults

Vaccination programs using the monovalent adjuvanted or bivalent vaccine against respiratory syncytial virus (RSV) were projected to be potentially cost-effective at a price per dose of up to $127 or up to $118, respectively, over a first RSV season.
https://acpinternist.org/weekly/archives/2023/12/05/4.htm
5 Dec 2023

Coadministration of zoster vaccine, COVID-19 booster appears safe, effective

An industry trial found that coadministration of an mRNA COVID-19 booster vaccine with a first dose of recombinant zoster vaccine was immunologically noninferior to spacing the shots two weeks apart, with a similar safety and reactogenicity profile.
https://immattersacp.org/weekly/archives/2023/06/27/2.htm
27 Jun 2023

Busting COVID-19 vaccination myths

Misinformation and disinformation campaigns have contributed to the death toll of the COVID-19 pandemic. Internists can effectively counter this and encourage vaccinations.
https://immattersacp.org/archives/2021/11/busting-covid-19-vaccination-myths.htm
1 Nov 2021

New COVID-19 vaccines tested, authorization changes in progress for existing vaccines

The FDA further limited use of the Johnson & Johnson (Janssen) vaccine and scheduled advisory committee meetings on other vaccine questions. Two non-mRNA vaccines showed effectiveness, and other studies looked at antibody prevalence, home test accuracy, and long-term symptoms.
https://immattersacp.org/weekly/archives/2022/05/10/2.htm
10 May 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next